Menu
  • Join
  • Login
  • Contact
 

Search abstracts


New anti-resistant antibiotic – piperacillin sodium and sulbactum sodium for injection (2:1)

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Poster
  • By: HUANG, Huimin (Welman Pharm R&D Centre, Guangzhou, China)
  • Co-author(s): Sun, Mingjie (Welman Pharm R&D Centre, GUANGZHOU, China)
    Lv, Huachong (Guangdong Pharmaceutical College, GUANGZHOU, China)
    Wang, Ting (Welman Pharm R&D Centre, GUANGZHOU, China)
  • Abstract:

    The pharmacologic action and clinical trial results of 'piperacillin sodium and sulbactum sodium (PIP/SBT) for injection (2:1)' were reviewed in this article. Methods: The therapeutic effect of PIP/SBT was confirmed by pharmacologic and antibiosis experiments in vitro and in vivo, tolerance and pharmacokinetics experiment with volunteer and..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses